Publications

Year Published

Type

Biomarker

Tumor Type

Meeting Type

With every passing day, new discoveries are made that lend support to the increasing and important role biomarker analysis and tumor profiling play in personalized cancer care. Caris Life Sciences® is actively participating in research to advance the understanding of molecular science, further enabling the delivery of precision medicine.

Mutational burden, immune checkpoint expression, and mismatch repair in glioma: implications for immune checkpoint immunotherapy
Comparative molecular profiling of HPV-induced squamous cell carcinomas
BRCA2, EGFR, and NTRK mutations in mismatch repair-deficient colorectal cancers with MSH2 or MLH1 mutations
Mismatch-repair deficiency predicts response of solid tumors to PD-1 blockade
RNASeq analysis of glioma tumors reveal targetable gene fusions
Localization of non-receptor tyrosine kinase (nRTK) variants identified in solid tumor patients with Next-Generation Sequencing (NGS)
Prevalence of homologous recombination deficiency among all tumor types
Colorectal cancer: Impact of primary tumor location on genetic alterations
Spectrum of tumor mutational load (TML) in genitourinary (GU) cancers
Potential therapeutic genomic alterations in desmoplastic small round blue cell tumor
Distribution of receptor tyrosine kinase (RTK) nsSNPs in breast cancer (BC) patients (pts) using Next-Generation Sequencing (NGS)
Characterization of tumor mutation load (TML) in solid tumors
Variable DNA mismatch repair associated gene profiles in colorectal versus uterine cancers
Molecular profiling comparison of breast cancer subtypes in young women and older women
Impact of patient age on molecular alterations in left-sided colorectal tumors